In vitro Susceptibility of Nontuberculous Mycobacteria to Tedizolid
Huiyun Zhang,1 Wenya Hua,1 Siran Lin,1 Yu Zhang,1 Xinchang Chen,1 Shiyong Wang,1 Jiazhen Chen,1 Wenhong Zhang1– 3 1Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Sh...
| Published in: | Infection and Drug Resistance |
|---|---|
| Main Authors: | Zhang H, Hua W, Lin S, Zhang Y, Chen X, Wang S, Chen J, Zhang W |
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2022-08-01
|
| Subjects: | |
| Online Access: | https://www.dovepress.com/in-vitro-susceptibility-of-nontuberculous-mycobacteria-to-tedizolid-peer-reviewed-fulltext-article-IDR |
Similar Items
Investigation of In vitro Efficacy of New Generation Drugs Tedizolid and Omadacycline against Nontuberculous Mycobacteria
by: Seda Türkkal Arli, et al.
Published: (2026-01-01)
by: Seda Türkkal Arli, et al.
Published: (2026-01-01)
Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China
by: Shu’an Wen, et al.
Published: (2021-08-01)
by: Shu’an Wen, et al.
Published: (2021-08-01)
Identification and drug susceptibility testing for nontuberculous mycobacteria
by: Wei-Chang Huang, et al.
Published: (2020-06-01)
by: Wei-Chang Huang, et al.
Published: (2020-06-01)
LC-MS/MS Method for Simultaneous Quantification of Three Oxazolidinone Antimicrobials in Human Plasma: Application to Therapeutic Drug Monitoring
by: Zhang N, et al.
Published: (2025-10-01)
by: Zhang N, et al.
Published: (2025-10-01)
Methodological Considerations in the Evaluation of Ciprofol’s Effect on Postoperative Delirium in Elderly Patients [Letter]
by: Lu Y, et al.
Published: (2025-10-01)
by: Lu Y, et al.
Published: (2025-10-01)
A Retrospective Study to Compare the Incidence of Hyponatremia after Administration between Linezolid and Tedizolid
by: Yuichi Shibata, et al.
Published: (2023-02-01)
by: Yuichi Shibata, et al.
Published: (2023-02-01)
In vitro susceptibility of nontuberculous mycobacteria in China
by: Weicong Ren, et al.
Published: (2024-01-01)
by: Weicong Ren, et al.
Published: (2024-01-01)
Portuguese in vitro antibiotic susceptibilities favor current nontuberculous mycobacteria treatment guidelines
by: Vera Durão, et al.
Published: (2019-05-01)
by: Vera Durão, et al.
Published: (2019-05-01)
Evaluation of drug susceptibility in nontuberculous mycobacteria using the SLOMYCO and RAPMYCO sensititre plates
by: Natalia Fernandes Garcia Carvalho, et al.
Published: (2021-01-01)
by: Natalia Fernandes Garcia Carvalho, et al.
Published: (2021-01-01)
In vitro activity of tedizolid against 43 species of Nocardia species
by: Masahiro Toyokawa, et al.
Published: (2024-03-01)
by: Masahiro Toyokawa, et al.
Published: (2024-03-01)
Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs
by: Eva Benavent, et al.
Published: (2021-01-01)
by: Eva Benavent, et al.
Published: (2021-01-01)
Isolation and Antimicrobial Susceptibility of Nontuberculous Mycobacteria in a Tertiary Hospital in Korea, 2016 to 2020
by: Keun Ju Kim, et al.
Published: (2023-01-01)
by: Keun Ju Kim, et al.
Published: (2023-01-01)
Highly Sensitive, Selective and Validated Spectrofluorimetric Assay for Novel Oxazolidinone Antibiotic: Tedizolid Phosphate in Pharmaceutical Dosage Form and Human Plasma
by: Rasha El-Eryan, et al.
Published: (2021-07-01)
by: Rasha El-Eryan, et al.
Published: (2021-07-01)
COMPARISON OF THE CLINICAL ACTIVITY OF TWO OXAZOLIDINONES – LINEZOLID AND TEDIZOLIDE: UNJUSTIFIED EXPECTATIONS
by: N. V. Dmitrieva, et al.
Published: (2018-11-01)
by: N. V. Dmitrieva, et al.
Published: (2018-11-01)
Study on the Efficacy and Safety of Tedizolid in Japanese Patients
by: Kazuhiro Ishikawa, et al.
Published: (2024-12-01)
by: Kazuhiro Ishikawa, et al.
Published: (2024-12-01)
Nontuberculous Mycobacteria, Botswana, 2011–2014
by: Bontle Mbeha, et al.
Published: (2019-07-01)
by: Bontle Mbeha, et al.
Published: (2019-07-01)
Genetic diversity of nontuberculous mycobacteria among symptomatic tuberculosis negative patients in Kenya
by: Zakayo Maingi Mwangi, et al.
Published: (2022-01-01)
by: Zakayo Maingi Mwangi, et al.
Published: (2022-01-01)
Recent advances on nontuberculous mycobacteria diseases in Asia
by: Po-Ren Hsueh
Published: (2015-01-01)
by: Po-Ren Hsueh
Published: (2015-01-01)
Occurrence of nontuberculous mycobacteria in aquatic sources of Sri Lanka
by: E A.R Edirisinghe, et al.
Published: (2014-01-01)
by: E A.R Edirisinghe, et al.
Published: (2014-01-01)
Nontuberculous Mycobacteria from Household Plumbing of Patients with Nontuberculous Mycobacteria Disease
by: Joseph O. Falkinham
Published: (2011-03-01)
by: Joseph O. Falkinham
Published: (2011-03-01)
NONTUBERCULOUS MYCOBACTERIA - CURRENT RISK IN BULGARIA
by: Yuliana Atanasova, et al.
Published: (2024-01-01)
by: Yuliana Atanasova, et al.
Published: (2024-01-01)
Evaluation and Comparison of Laboratory Methods in Diagnosing Mycobacterium tuberculosis and Nontuberculous Mycobacteria in 3012 Sputum Samples
by: Qian Wu, et al.
Published: (2025-03-01)
by: Qian Wu, et al.
Published: (2025-03-01)
Assessment of Drug Resistance in Nontuberculous Mycobacteria
by: Anastasia Kazulina, et al.
Published: (2024-12-01)
by: Anastasia Kazulina, et al.
Published: (2024-12-01)
Pulmonary Nontuberculous Mycobacteria, Ontario, Canada, 2020
by: Theodore K. Marras, et al.
Published: (2023-07-01)
by: Theodore K. Marras, et al.
Published: (2023-07-01)
Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada
by: Sarah K. Brode, et al.
Published: (2017-11-01)
by: Sarah K. Brode, et al.
Published: (2017-11-01)
Epidemiology of nontuberculous mycobacteria in the Finger Lakes region of New York
by: Michael Croix, et al.
Published: (2024-12-01)
by: Michael Croix, et al.
Published: (2024-12-01)
Hematological profiles of patients with tuberculosis and nontuberculous mycobacteria infections in Bamako, Mali
by: Fanta Sanogo, et al.
Published: (2023-01-01)
by: Fanta Sanogo, et al.
Published: (2023-01-01)
Bibliometric Analysis of Nontuberculous Mycobacteria Research in South Korea
by: Geunin Lee, et al.
Published: (2025-04-01)
by: Geunin Lee, et al.
Published: (2025-04-01)
Nontuberculous Mycobacteria, Zambia
by: Patricia C.A.M. Buijtels, et al.
Published: (2009-02-01)
by: Patricia C.A.M. Buijtels, et al.
Published: (2009-02-01)
Nontuberculous Mycobacteria and Laboratory Surveillance, Virginia, USA
by: Isaac See, et al.
Published: (2024-06-01)
by: Isaac See, et al.
Published: (2024-06-01)
Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research
by: Elisa Rampacci, et al.
Published: (2020-08-01)
by: Elisa Rampacci, et al.
Published: (2020-08-01)
Current Problems of Infections Caused by MRSA and Ways to Address Them
by: S. K. Zyryanov, et al.
Published: (2020-05-01)
by: S. K. Zyryanov, et al.
Published: (2020-05-01)
Cutaneous Nontuberculous Mycobacteria Infections Following Cosmetic Procedures: A Retrospective Study
by: Zeng R, et al.
Published: (2025-05-01)
by: Zeng R, et al.
Published: (2025-05-01)
Epidemiology and clinical outcomes in skin and soft tissue nontuberculous mycobacteria infections: A retrospective study
by: Jia Zhou, et al.
Published: (2025-03-01)
by: Jia Zhou, et al.
Published: (2025-03-01)
Mycobacteria mobility shift assay: a method for the rapid identification of Mycobacterium tuberculosis and nontuberculous mycobacteria
by: Letícia Muraro Wildner, et al.
Published: (2014-06-01)
by: Letícia Muraro Wildner, et al.
Published: (2014-06-01)
Shower dehumidification to reduce nontuberculous mycobacteria aerosolization
by: Michael X. Kostecki, et al.
Published: (2024-03-01)
by: Michael X. Kostecki, et al.
Published: (2024-03-01)
Clinical Relevance of Nontuberculous Mycobacteria, Oman
by: Sara H. Al-Mahruqi, et al.
Published: (2009-02-01)
by: Sara H. Al-Mahruqi, et al.
Published: (2009-02-01)
Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models
by: Saloni Saxena, et al.
Published: (2021-01-01)
by: Saloni Saxena, et al.
Published: (2021-01-01)
Nontuberculous Mycobacteria in Horses: A Narrative Review
by: Lynna Li, et al.
Published: (2023-07-01)
by: Lynna Li, et al.
Published: (2023-07-01)
Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria
by: Alicia Rodríguez-Gascón, et al.
Published: (2021-06-01)
by: Alicia Rodríguez-Gascón, et al.
Published: (2021-06-01)
Similar Items
-
Investigation of In vitro Efficacy of New Generation Drugs Tedizolid and Omadacycline against Nontuberculous Mycobacteria
by: Seda Türkkal Arli, et al.
Published: (2026-01-01) -
Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China
by: Shu’an Wen, et al.
Published: (2021-08-01) -
Identification and drug susceptibility testing for nontuberculous mycobacteria
by: Wei-Chang Huang, et al.
Published: (2020-06-01) -
LC-MS/MS Method for Simultaneous Quantification of Three Oxazolidinone Antimicrobials in Human Plasma: Application to Therapeutic Drug Monitoring
by: Zhang N, et al.
Published: (2025-10-01) -
Methodological Considerations in the Evaluation of Ciprofol’s Effect on Postoperative Delirium in Elderly Patients [Letter]
by: Lu Y, et al.
Published: (2025-10-01)
